Trial intelligence / Profile preview

Dose-response study of norepinephrine to prevent spinal anesthesia- and oxytocin-induced hypotension during cesarean section

ChiCTR1800014614Phase 3Recruiting

Sponsor
Jiaxing Maternity and Child Health Care Hospital
Start
Feb 2018
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of norepinephrine in hypotension (5 arms), sponsored by Jiaxing Maternity and Child Health Care Hospital. Primary endpoint: blood pressure. Started Feb 2018; status: recruiting.

02

Drugs

norepinephrine
03

Conditions

hypotension

Beyond the preview

Go deeper on ChiCTR1800014614.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800014614.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call